Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William L. Clark, M.D.
Palmetto Retina Center, LLC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southeast Retina
Augusta, Georgia, United States
- Eye Surgical Associates
Lincoln, Nebraska, United States
- Palmetto Retina Center
West Columbia, South Carolina, United States
- Black Hills Regional Eye Institute
Rapid City, South Dakota, United States
- Retina Consultants Houston
Houston, Texas, United States
- Rocky Mountain Retina
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2013
- Primary completion
- 31 Mar 2016
- Completion
- 31 Jul 2016
- Last update posted
- 30 Oct 2015
- Registered enrollment
- 45
- Registry id
- NCT01961414
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.